Sign in

Trial site

CHUM - University Hospital of Montreal

Montreal, Quebec H2X 3E4, CanadaNot linked to an institution yet
  • 1running trial
  • 1closed trial

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 32 trials
Status
  • Active, not recruiting1 trial
  • Completed1 trial
Lead sponsor
  • Endocyte1 trial
  • POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company1 trial

Running trials

Closed trials

Site data: ClinicalTrials.govUpdated 12 Nov 2026

CHUM - University Hospital of Montreal: trial site – Frontlight Research